A study found that people with a history of gestational diabetes are more likely to develop type 2 diabetes within nine years after delivery, particularly in Black and Hispanic women. Regular diabetes screenings in the early postpartum period can alter disease progression and improve control.
Researchers identified three immune cell types within tumor niches that determine which patients respond positively to checkpoint blockade immunotherapy. The study may inform new approaches to cancer treatment.
Researchers at Mount Sinai have developed an AI model called HeartBEiT that can analyze electrocardiograms as language, enabling more accurate diagnoses. The model outperformed established methods in comparison tests and demonstrated improved performance with lower sample sizes.
Researchers from Mount Sinai Health System presented new findings on the impact of customized lighting on inpatient sleep, a machine-learned combination of ventilatory, hypoxic, and arousal burdens, and the effects of obstructive sleep apnea and insomnia on cognitive impairment. The studies aim to improve sleep timing and duration, dia...
Researchers have identified a novel model and therapy to mitigate the development of REM sleep behavior disorder, which affects over 3 million Americans. Dual orexin receptor antagonists have been shown to significantly reduce dream enactment behaviors, providing a promising new treatment option.
Researchers from Mount Sinai Health System will present studies on pediatric pulmonary vascular disease, asthma, and sleep disorders. The findings focus on prevalence of pulmonary hypertension in children with severe obstructive sleep apnea and associations between diet and lung function decline.
Dr. George Dangas has been appointed as the new President of SCAI, a non-profit professional association promoting excellence in interventional cardiovascular medicine. He is an authoritative voice on nonsurgical cardiovascular and valve interventions, and will fulfill various responsibilities including acting as spokesperson for SCAI.
A new machine learning-based model predicts individual cardiac surgery patient mortality risk with improved performance over current population-derived models. The model uses electronic health records to provide personalized risk assessments, offering a significant advantage over existing benchmarks.
A global clinical trial found that bioresorbable vascular scaffolds (BVS) are nearly as safe and effective as conventional metal stents in treating coronary artery disease. The study, led by a researcher from the Mount Sinai Hospital, showed improved outcomes for patients when properly implanted.
A new human pangenome reference has been created, capturing significantly more human diversity than the previous single reference. The reference includes genome sequences of 47 people and aims to increase that number to 350 by mid-2024.
Researchers at Mount Sinai have discovered a previously unknown way in which the brain and immune system interact in multiple sclerosis. They found that the inflammatory protein interleukin-3 (IL-3) coordinates this communication, inciting the recruitment of immune cells to the brain and exacerbating brain inflammation.
Researchers at Mount Sinai Hospital developed a machine learning model to analyze wearable device data, identifying an individual's degree of resilience and psychological well-being. The study found that heart rate variability and resting heart rate metrics collected from Apple Watches were predictive of resilience states.
Researchers at Mount Sinai have discovered a new therapeutic approach to treating non-small-cell lung cancer by inhibiting immune system molecule TREM2 and enhancing natural killer cells. The strategy, which involves blocking TREM2 activity using an antibody, has been shown to significantly reduce lung tumor growth in mice.
Researchers at The Mount Sinai Hospital have created versatile disease models of acute myeloid leukemia (AML), allowing for accurate study of the cancer's progression and response to drugs. These models, derived from induced pluripotent stem cells, can mimic different stages of AML and are nearly identical to those found in patients.
Researchers identified potential novel receptors for SARS-CoV-2 that utilize multiple receptors to facilitate its life cycle. The study reveals a strong correlation between tissue age-dependency and SARS-CoV-2 infection-induced receptor expression, with older adults being more susceptible to severe outcomes.
Researchers at the Icahn School of Medicine at Mount Sinai identified previously unknown genetic causes of three rare diseases: primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness. The study used a computational approach to analyze large genetic datasets from rare disease cohorts.
Researchers have identified two novel genes, SRRM2 and AKAP11, linked to schizophrenia. The study suggests that rare damaging variants in these genes confer a similar magnitude of schizophrenia risk across diverse human populations. This finding has implications for the development of new treatments for the disease.
A phase 2 study found that ANGPTL3 inhibitor therapy reduced triglycerides by up to 70% in patients with severe hypertriglyceridemia who had previously experienced acute pancreatitis. The treatment, evicanumab-dgnb, also showed potential for cardiovascular prevention by reducing apolipoprotein B levels.
High-dose anticoagulation reduces intubations and deaths by 30% in hospitalized COVID-19 patients, especially those with ARDS. The study found a significant reduction in mortality and need for ICU care among patients treated with therapeutic anticoagulation.
A new study shows that transcatheter mitral valve repair significantly reduces hospitalizations by almost 50 percent and death by nearly 30 percent in heart failure patients with severe mitral regurgitation. The procedure, using Abbott's MitraClip system, improves symptoms, reduces hospitalizations, and leads to longer survival.
Researchers created a novel approach to deliver anti-cancer drugs directly to brain tumor sites in children, targeting specific locations while sparing normal brain regions. This targeted delivery method enhances the efficacy of existing treatments and reduces adverse side effects.
A recent study published in Immunity found that skipping breakfast can lead to a decline in immune cells and an increased risk of heart disease. The research showed that fasting triggers a stress response in the brain, which negatively affects immune cells.
Scientists have identified key players in the adaptive immune response as culprits for most autoimmunity in people with Down syndrome. The researchers found that many individuals with Down syndrome are in a perpetual state of inflammation comparable to those without the disorder who are in intensive care.
Researchers found 270 distinct differentially methylated regions (DMRs) in AD brains compared to normal controls, validating their key findings using an independent cohort. The study offers a novel approach to investigating the relationship between DNA methylation and gene/protein expression.
Researchers have generated induced pluripotent stem cells from bats, gaining insights into the relationship between bats and viruses. The study may also shed light on bats' remarkable defenses against aging and cancer.
A US study found that COVID-19 vaccination is associated with a lower risk of cardiovascular events, particularly among those with comorbidities. Even partial vaccination was linked to a reduced risk of adverse cardiovascular events. The research suggests that vaccination may have beneficial effects on post-COVID-19 complications.
Researchers from Mount Sinai Health System presented studies on the association between obesity and adverse outcomes in forceps-assisted vaginal deliveries, as well as the utility of cervical length surveillance after cerclage placement for predicting preterm birth. Additionally, a new tool for managing postpartum hemorrhage was showca...
Research found that cocaine use disorder causes significant gene expression changes in brain regions associated with reward and habit formation, contributing to persistent behavioral abnormalities. The study also identified overlapping molecular changes between cocaine and opioid use disorders, offering potential for targeted treatments.
A Phase 2 clinical trial found that patients with notalgia paresthetica experienced a significant reduction in itch intensity after taking oral difelikefalin. The medication, currently approved for chronic kidney disease, has the potential to become the first FDA-approved treatment specifically for this condition.
Researchers will use systems biology approach to identify biomarkers and mechanisms underlying food allergies and atopic dermatitis. The study aims to improve prevention, diagnosis, and clinical management of these conditions.
The study reveals that repeated mutations in the sarZ gene lead to increased severity of MRSA blood stream infections, and that surface protein ClfB plays a critical role in pathogenesis. The findings provide insights into the factors contributing to MRSA virulence and may help uncover new treatment approaches.
Researchers found that mice exposed to WTCPM dust exhibit impaired spatial recognition and memory, as well as changes in genes related to immune-inflammatory responses. The study suggests a peripheral-brain immune inflammatory 'cross-talking' mechanism that may increase cognitive decline risk.
Mount Sinai researchers discovered that age-related macular degeneration (AMD) may be caused by two distinct types of deposits in the retina: drusen and subretinal drusenoid deposits (SDDs). Early intervention with vitamin supplements can slow down drusen formation, while SDDs pose a greater threat to advanced AMD.
Researchers have identified novel candidate drug targets for advanced non-alcoholic fatty liver disease (NAFLD) using innovative methods. A network of cell-to-cell communication driving scarring was uncovered, and one pair of proteins showed promise as a new treatment.
Researchers at Mount Sinai developed a digital marker for coronary artery disease using machine learning and electronic health records. The model accurately measures CAD on a spectrum, revealing distinct gradations of disease risk and survival, which may otherwise be missed with conventional binary frameworks.
Researchers from The Mount Sinai Hospital found that talquetamab, a bispecific antibody, was successful in killing multiple myeloma cells in over 70% of patients. This therapy directs the immune system to target cancer cells and has shown promise even for those who have resisted all other treatments.
Patients with moderate to severe atopic dermatitis showed significant improvement in signs and symptoms while taking rocatinlimab, a novel monoclonal antibody therapy. The treatment has the potential to change the genetic makeup of the disease, leading to lasting results without continued use.
Researchers identified two molecularly distinct subsets of long COVID symptoms with opposing gene expression patterns during acute COVID-19. These findings suggest multiple independent processes leading to different long COVID symptoms, which are already present during the acute infection.
A Mount Sinai study found that certain inflammatory markers can predict which patients are more likely to respond to COVID-19 immunotherapies. The researchers identified a subtype of COVID-19 patients with hyperinflammation who could benefit from pacritinib, an anti-cancer drug.
Researchers identify INPP5D as a key player in the inflammation process contributing to Alzheimer's disease, which may offer new potential targets for therapies. The study found that mice with inactivated INPP5D gene had more plaques covered by microglia, suggesting unexpected results when modulating inflammation genes.
Chronic social defeat stress impairs brain reward function, leading to severe social avoidance. A subset of susceptible mice exhibit heightened activity of lateral septum neurotensin neurons, which inhibit centers encoding social rewards.
A large-scale international study found that patients diagnosed with lung cancer at an early stage via CT screening have a 20-year survival rate of 80 percent. This is compared to the average five-year survival rate for all lung cancer patients, which is 18.6 percent.
A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.
A recent study published in Cell Reports Medicine has identified 35 genes highly expressed in patients with long-term Lyme disease. These genes may serve as biomarkers for diagnosing the condition, which is often difficult to detect. The findings also suggest new therapeutic targets and could lead to improved management of the disease.
Researchers found significant immunological differences mediating sex differences in COVID-19 responses. Infected females had higher rates of symptoms but lower viral loads, with stronger immune response gene expression and molecular signatures.
A new study has shown that bivalirudin is a safer and more effective anticoagulant than heparin for treating heart attack patients. The trial found that bivalirudin significantly reduced death, major bleeding, and thrombosis in patients undergoing percutaneous coronary intervention.
Researchers have found therapies that can help patients with relapsed multiple myeloma who tried CAR-T therapy, including bispecific antibodies and other types of CAR-T cell therapy. The study analyzed 79 patients and found that stem cell transplants and other drug combinations showed some efficacy in these patients.
A new metric estimates cumulative exposure to PFAS chemicals, enabling comparisons across studies and applications. The calculator takes into account patterns of exposure to multiple chemicals, providing a robust tool for biomonitoring and disease assessment.
Mount Sinai researchers catalogued thousands of sites in the brain where RNA is modified throughout the human lifespan, increasing with age. This study provides a model depicting how A-to-I editing evolves over a lifetime, shedding light on its role in health and disease.
A recent study found that immigrant pregnant people faced persistent inequities in obtaining timely prenatal care compared to native-born individuals, exacerbating longstanding health disadvantages. The study highlights the need for policymakers to address disparities in Medicaid coverage based on immigration status and education level.